REVIEW STUDY OF CASES OF HEPATOMEGALY IN INDIA: CHALLENGES, AWARENESS AND MANAGEMENT (KEY IJP************257)

• Rajat Beniwal,Shravani Kiran Dhatrak

Abstract

Hepatomegaly, or liver enlargement, is a common clinical finding that can result from a wide range of hepatic, systemic, and infectious conditions. In India, hepatomegaly often reflects the high burden of infectious diseases, metabolic disorders, non-communicable diseases .In India, hepatomegaly is commonly observed in both rural and urban regions, but the prevalence and underlying causes can vary significantly depending on geographic location, socioeconomic status, and local diseases.The burden of liver disease in India is significant because it alone contributed to 18.3% of the two million global liver diseaserelated deaths in 2015. The culturallifestyle transition that India is passing through currently with progressive adoption of a western diet, sedentary habits, along with an aura of freedom from longheld taboos around alcohol in the society create grounds for a spectrum of liver diseases in India that shows signs of a rapid switch. The expanding size of the population and an increasing life expectancy in the country are important demographic determinants of this change. In keeping with this, encouraging health system response strategies have been adopted in India. A federally funded National Viral Hepatitis Control Program is operational in India since 2018 that includes both preventive (vaccination, blood safety) and early detection: linkagetocare (screening atrisk population, provision of drugs, surveillance of CLD) strategies